GLUCOSAMINE & ARTHRITIS.In May, we said that a new National Institutes of Health (NIH "Not invented here." See digispeak. NIH - The United States National Institutes of Health. ) study called GAIT (Glucosamine/Chondroitin Arthritis arthritis, painful inflammation of a joint or joints of the body, usually producing heat and redness. There are many kinds of arthritis. In its various forms, arthritis disables more people than any other chronic disorder. Intervention Trial) would use the Cosamin brand ("Quick Studies,' page 9). Not so. The study will use the same glucosamine glucosamine /glu·co·sa·mine/ (gloo-ko´sah-men) an amino derivative of glucose, occurring in glycosaminoglycans and a variety of complex polysaccharides such as blood group substances. and chondroitin chondroitin (k n formulations that are found in Cosamin, the only U.S. brand that contains them. We also printed an incorrect phone number for readers who want to volunteer for the study. If you're interested in volunteering, you need to: (1) be 40 or older, (2) have been diagnosed with osteoarthritis osteoarthritis or osteoarthrosis or degenerative joint disease Most common joint disorder, afflicting over 80% of those who reach age 70. It does not involve excessive inflammation and may have no symptoms, especially at first. of the knee, (3) not have any other arthritis-like disease (like gout gout, condition that manifests itself as recurrent attacks of acute arthritis, which may become chronic and deforming. It results from deposits of uric acid crystals in connective tissue or joints. ), (4) not have diabetes, (5) be willing to stop taking glucosamine or chondroitin (if you're currently taking either or both), (6) be willing to take a COX-2 inhibitor cox-2 inhibitor: see nonsteroidal anti-inflammatory drug. drug (like Celebrex or Vioxx), and (7) be willing to travel to one of the centers where the study will take place. The best way to contact the study is by e-mailing the center nearest you. If you can't e-mail, leave a message at (801) 587-9627 (it's in Utah). ALABAMA University of Alabama, Birmingham tina.parkhill@ccc.uab.edu CALIFORNIA Cedars-Sinai Medical Center, Beverly Hills guiglianoa@cshs.org University of California, San Francisco rthiess@itsa.ucsf.edu INDIANA Indiana University, Indianapolis hcountry@iupui.edu KANSAS Arthritis Research Center Foundation, Wichita kathyu@arthritis-research.org NEBRASKA University of Nebraska Medical Center, Omaha dogrady@unmc.edu NEW YORK Hospital for Joint Diseases, New York City vivian.abellana@med.nyu.edu OHIO Case Western Reserve University, Beechwood lernans71@aol.com PENNSYLVANIA Hospital of the University of Pennsylvania, Philadelphia ms_sieck@hotmail.com University of Pittsburgh pauli@msx.dept-med.pitt.edu TEXAS Presbyterian Hospital of Dallas emmabarnboym@texashealth.org UTAH University of Utah, Salt Lake City alisa.kim@hsc.utah.edu WASHINGTON Virginia Mason Research Center, Seattle crgesv@vmrnc.org |
|
||||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion